Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > Spectral on Linkedin Today

<< Previous

Bullboard Posts

Next >>

Comment by PezDalatoYouon Dec 07, 2024 1:36pm

128 Views

Post# 36351104

RE:Spectral on Linkedin Today

I find it interesting that Spectral continues to post in a positive manner on LinkedIn. Given that they already know the direction of the trial outcome, I think it would be a fraud to continue to publicly post this stuff if the trial is headed in a negative direction. Although my trust in the management team doesn't totally dismiss a fraud, an intentional and obvious fraud would be unlikely, I think.

Thoughts?

<< Previous

Bullboard Posts

Next >>

Invest wiser with BMO's InvestorLine Platform features